High-dose glibenclamide can replace insulin therapy despite transitory diarrhea in early-onset diabetes caused by a novel R201L Kir6.2 mutation
Más información
| Título según WOS: | High-dose glibenclamide can replace insulin therapy despite transitory diarrhea in early-onset diabetes caused by a novel R201L Kir6.2 mutation |
| Título según SCOPUS: | High-dose glibenclamide can replace insulin therapy despite transitory diarrhea in early-onset diabetes caused by a novel R201L Kir6.2 mutation |
| Título de la Revista: | DIABETES CARE |
| Volumen: | 28 |
| Número: | 3 |
| Editorial: | AMER DIABETES ASSOC |
| Fecha de publicación: | 2005 |
| Página de inicio: | 758 |
| Página final: | 759 |
| Idioma: | English |
| URL: | http://care.diabetesjournals.org/cgi/doi/10.2337/diacare.28.3.758 |
| DOI: |
10.2337/diacare.28.3.758 |
| Notas: | ISI, SCOPUS |